Invention Grant
- Patent Title: Topical treatment of inflammatory bowel disease using antibodies and fragments thereof
-
Application No.: US16616460Application Date: 2018-04-26
-
Publication No.: US11717484B2Publication Date: 2023-08-08
- Inventor: Vipul Yadav , Abdul Waseh Basit , Felipe José Oliveira Varum , Roberto Carlos Bravo Gonzaléz , Esther Maria Furrer
- Applicant: Tillotts Pharma AG , University College London
- Applicant Address: CH Rheinfelden
- Assignee: Tillotts Pharma AG,University College London
- Current Assignee: Tillotts Pharma AG,University College London
- Current Assignee Address: CH Rheinfelden; GB England
- Agency: Smith Patent, LLC
- Agent Chalin A. Smith
- Priority: EP 173847 2017.05.31
- International Application: PCT/EP2018/060690 2018.04.26
- International Announcement: WO2018/219559A 2018.12.06
- Date entered country: 2019-11-23
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K9/00 ; C07K16/24
Abstract:
The present invention relates to the therapeutic uses of compositions containing antibody molecules and functional fragments thereof, e.g antibody molecules and functional fragments capable of binding to tumor necrosis factor alpha (TNFα), in the topical treatment of inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
Public/Granted literature
- US20200170956A1 TOPICAL TREATMENT OF INFLAMMATORY BOWEL DISEASE USING ANTIBODIES AND FRAGMENTS THEREOF Public/Granted day:2020-06-04
Information query
